August J. Troendle, the CEO of $MEDP, sold 5,128 shares of the company on 11-13-2025 for an estimated $3,083,825. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.6% of their shares of this class of stock. Following this trade, they now own 914,162 shares of this class of $MEDP stock.
$MEDP Insider Trading Activity
$MEDP insiders have traded $MEDP stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.
Here’s a breakdown of recent trading of $MEDP stock by insiders over the last 6 months:
- AUGUST J. TROENDLE (CEO) has made 0 purchases and 6 sales selling 96,940 shares for an estimated $46,278,159.
- JESSE J GEIGER (President) has made 0 purchases and 4 sales selling 86,332 shares for an estimated $45,611,843.
- SUSAN E BURWIG (Exec. VP, Operations) has made 0 purchases and 4 sales selling 37,500 shares for an estimated $20,276,070.
- STEPHEN P EWALD (General Counsel & Corp. Secy.) has made 0 purchases and 2 sales selling 18,230 shares for an estimated $10,470,485.
- KEVIN M. BRADY (CFO & Treasurer) sold 12,000 shares for an estimated $5,450,760
- FRED B JR DAVENPORT sold 5,972 shares for an estimated $3,474,987
- CORNELIUS P. III MCCARTHY sold 1,662 shares for an estimated $772,896
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$MEDP Hedge Fund Activity
We have seen 319 institutional investors add shares of $MEDP stock to their portfolio, and 348 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TD ASSET MANAGEMENT INC removed 329,498 shares (-72.0%) from their portfolio in Q3 2025, for an estimated $169,414,691
- EPOCH INVESTMENT PARTNERS, INC. removed 319,530 shares (-71.8%) from their portfolio in Q3 2025, for an estimated $164,289,544
- JANE STREET GROUP, LLC added 268,651 shares (+622.9%) to their portfolio in Q2 2025, for an estimated $84,318,802
- MILLENNIUM MANAGEMENT LLC added 252,169 shares (+271.8%) to their portfolio in Q2 2025, for an estimated $79,145,762
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 211,411 shares (+205.8%) to their portfolio in Q3 2025, for an estimated $108,699,079
- TWO SIGMA ADVISERS, LP removed 190,200 shares (-68.3%) from their portfolio in Q3 2025, for an estimated $97,793,232
- GOLDMAN SACHS GROUP INC removed 184,546 shares (-65.4%) from their portfolio in Q2 2025, for an estimated $57,921,607
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$MEDP Congressional Stock Trading
Members of Congress have traded $MEDP stock 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $MEDP stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 07/22 and 1 sale worth up to $15,000 on 08/04.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 07/24.
- REPRESENTATIVE DAVID TAYLOR sold up to $15,000 on 07/23.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$MEDP Analyst Ratings
Wall Street analysts have issued reports on $MEDP in the last several months. We have seen 1 firms issue buy ratings on the stock, and 3 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Underweight" rating on 10/24/2025
- Mizuho issued a "Outperform" rating on 10/24/2025
- TD Cowen issued a "Sell" rating on 10/24/2025
- UBS issued a "Sell" rating on 07/29/2025
To track analyst ratings and price targets for $MEDP, check out Quiver Quantitative's $MEDP forecast page.
$MEDP Price Targets
Multiple analysts have issued price targets for $MEDP recently. We have seen 10 analysts offer price targets for $MEDP in the last 6 months, with a median target of $468.0.
Here are some recent targets:
- Sean Dodge from BMO Capital set a target price of $600.0 on 11/13/2025
- Luke Sergott from Barclays set a target price of $485.0 on 10/24/2025
- Charles Rhyee from TD Cowen set a target price of $462.0 on 10/24/2025
- Ann Hynes from Mizuho set a target price of $655.0 on 10/24/2025
- David Windley from Jefferies set a target price of $450.0 on 09/09/2025
- Jamie Clark from Rothschild & Co set a target price of $474.0 on 09/03/2025
- Dan Leonard from UBS set a target price of $305.0 on 07/29/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
